Abnormalities in the GH-JAK2-STAT5 signaling pathway altered the whole-body fat metabolism to promote peripheral lipolysis while enhancing hepatic fat synthesis, resulting in hepatic fat accumulation and leading to the development of the NAFLD phenotype [12]. Here, GH1 is linked to metabolic dysfunction-associated steatotic liver disease.